Study at a glance
Does measuring free vitamin D give more useful information than the total?
This page asks whether measuring free vitamin D gives more useful information than measuring the total amount. The studies measured 25-hydroxyvitamin D. Most of this form is carried by proteins in blood. Free means unattached to these proteins; total includes both attached and free amounts.
Who was studied to compare free and total vitamin D tests?
Several human studies included healthy adults, pregnant women, people with liver disease and nursing-home residents. A study of 155 people compared free amounts measured directly with amounts estimated using calculations. Other studies examined inherited carrier differences, supplement responses and rare cases of missing carrier protein.
When did free and total vitamin D results differ?
Free and total measurements often changed together, but their relationship differed in some health conditions. People with severe liver disease could have low total levels without low free levels. Calculated free amounts did not closely match direct measurements in the 155-person study. In another study, the laboratory method created large apparent differences between population groups that other methods did not reproduce.
Should free vitamin D testing replace total testing for everyone?
Total measurements remain useful, but carrier proteins and laboratory methods affect how results should be understood. Free measurements may add information when carrier proteins change greatly. The evidence does not show that free testing should replace total testing for everyone or that it leads to better health. Neither measurement directly shows how vitamin D acts in every tissue.
Read the full article below ↓The clinical question is not simply free versus total
Total 25(OH)D is widely used because it captures the main circulating reservoir and is supported by established laboratory practice. Free 25(OH)D asks a narrower physical question: how much 25(OH)D is unbound at the time of measurement? Because most 25(OH)D is protein-bound, the two measures can respond differently when DBP or albumin changes. See Study Summary.
That difference creates a tempting hierarchy in which free must be more biologically meaningful. The human evidence does not support that blanket conclusion. The relevant question is conditional: when does carrier biology or assay behaviour make total concentration less representative of the free pool, and does measuring free improve interpretation enough to matter clinically?
Direct measurement and calculation are different analytical routes
Free 25(OH)D can be measured directly or estimated mathematically from total 25(OH)D, DBP, albumin and assumed binding constants. Those routes should not be treated as equivalent. A calculation inherits every error in the measured inputs and every assumption in the affinity model. If the DBP assay is biased by genotype, the calculated free value can be biased even when the mathematics is executed perfectly.
Schwartz and colleagues compared directly measured and calculated free 25(OH)D in 155 people, including 24 with cirrhosis and 20 pregnant women. Calculated free 25(OH)D correlated with direct measurement, but it explained only about 13% of the variability and tended to be higher. This is a major warning against treating calculated free 25(OH)D as a transparent substitute for direct measurement.
The wider distinction between analytical variability and biology is developed in Variability in Vitamin D Measurements and Limitations of Vitamin D Blood Tests.
DBP assay choice can create an apparent biological difference
Nielson and colleagues examined 1,057 men from US, UK and Gambian populations using several ways of assessing DBP, including monoclonal and polyclonal immunoassays and proteomic measurement. The monoclonal assay produced large apparent ancestry-associated differences in DBP that were not reproduced by the other methods. This mattered because DBP values had been used to calculate free or “bioavailable” vitamin D.
Directly measured free 25OHD correlated strongly with total 25OHD, at roughly r = 0.84, and the dramatic racial-genotypic pattern inferred from the problematic DBP assay was not supported across the alternative methods. The lesson is not that genotype never matters. It is that an assay can manufacture or magnify a biological-looking difference when its binding to DBP variants is unequal.
This finding materially changed how earlier claims about ancestry, DBP and calculated bioavailable vitamin D should be read. It is a good example of why measurement architecture belongs inside scientific interpretation rather than in a footnote.
Ordinary DBP phenotypes do not create two separate monitoring systems
Sollid and colleagues used samples from a randomised supplementation study involving 472 adults. They measured total 25(OH)D by LC-MS/MS, directly measured free 25(OH)D and DBP phenotype. Common phenotypes were associated with differences in DBP and total 25(OH)D, while differences were smaller for free 25(OH)D.
Vitamin D supplementation increased the measured vitamin D variables, but the response did not materially diverge according to DBP phenotype, sex or age. This is important negative evidence. It argues against assuming that ordinary genetic variation in DBP requires a completely different clinical monitoring strategy.
The study also shows why the free-total question cannot be answered by rare genetics alone. Common variation is a much more relevant test of routine physiology, and here the two measures remained substantially coupled.
Cirrhosis is a clear example of altered binding context
Cirrhosis can reduce albumin and DBP, making it a strong test of what happens when carrier capacity changes. In the 2014 Schwartz study, total 25(OH)D, DBP and albumin were lowest in the cirrhosis group, yet directly measured free 25(OH)D was highest. Earlier liver-disease work likewise found lower total concentrations with a higher percentage free and broadly preserved absolute free 25(OH)D.
These observations show that total 25(OH)D can become harder to interpret in a major altered-protein state. They do not establish a universal cirrhosis-specific free 25(OH)D threshold, nor do they prove that free measurement predicts clinical outcomes better. They establish divergence in the measured compartments.
The measurement lesson is that a low total result can partly reflect reduced carrier capacity rather than a proportionate fall in every circulating fraction. This does not make the total result meaningless; it changes the physiological context in which the number should be interpreted.
Pregnancy changes DBP without producing a simple free-hormone prediction
Pregnancy provides the opposite carrier perturbation because DBP rises. A simple calculation might predict that more binding protein should necessarily drive free 25(OH)D downward. In the 2014 direct-measurement study, DBP was highest in pregnant participants, but measured free 25(OH)D did not differ significantly from the comparison group.
That result is useful because it resists an overly mechanical interpretation of binding equations. Physiology can alter total concentration, carrier abundance and equilibrium together. Direct measurement can therefore reveal a relationship that is less intuitive than a calculation based on fixed assumptions.
The conclusion here remains restricted to how pregnancy demonstrates that binding-state changes can complicate free-total interpretation. The study does not establish a pregnancy-specific universal free 25(OH)D target or a general rule that total 25(OH)D becomes uninformative during pregnancy.
A larger multicentre dataset maps where the relationship changes
The 2018 Schwartz analysis combined data from seven academic sites and 1,661 adults. The population included healthy adults, people with prediabetes, general outpatients, people with cirrhosis, pregnant women and nursing-home residents. Total 25(OH)D was measured by LC-MS/MS and free 25(OH)D by a direct immunoassay, with DBP, albumin, creatinine, PTH and DBP haplotype also available.
Across this diverse population, free and total 25(OH)D remained related, but the relationship was not identical across health states. Cirrhosis and nursing-home groups showed notable differences, and BMI contributed additional variation. The study therefore supports a model in which total is usually informative while particular physiological or clinical states alter the conversion between total and free.
Crucially, the investigators did not claim that this established clinical superiority of free 25(OH)D. They concluded that the clinical importance of free measurement still needed outcome-based investigation. That boundary remains central.
Rare DBP deficiency proves divergence but not routine superiority
The Henderson GC-deletion case is an extreme stress test of total 25(OH)D interpretation. With essentially no circulating DBP, total 25(OH)D was extraordinarily low while free 25(OH)D was far less extreme and mineral homeostasis was comparatively preserved. Banerjee’s later unrelated GC loss-of-function case reinforced the point that severe reductions in total vitamin D metabolites caused by absent DBP do not necessarily produce the phenotype predicted from total concentration alone.
These cases are compelling because they remove the carrier rather than merely correlating carrier concentration with vitamin D measurements. They are also clinically exceptional. A rare homozygous loss-of-function genotype cannot be used to conclude that a person with normal DBP and an ordinary low total 25(OH)D has adequate free vitamin D or adequate tissue action.
The physiological basis for that distinction is developed in Vitamin D Binding Protein Explained and Free, Albumin-Bound and Total Vitamin D in the Blood: Full Study.
Does free 25(OH)D predict physiology better?
The evidence is mixed and does not justify a universal yes. Some studies in altered binding states find free measures more closely aligned with the physiological situation than total alone. Within the selected human evidence, PTH relationships do not establish a consistent advantage for free measurement, and supplementation data show that total and free often move together.
This is exactly what the binding model predicts. When DBP and albumin behave within ordinary ranges, total concentration carries substantial information about the free pool. When carrier concentration, affinity or assay measurement is abnormal, the mapping can loosen. A test can therefore be more informative in a subgroup without being a universally superior replacement.
This distinction is consistent with What Vitamin D Levels Represent: a circulating concentration is a marker within a physiological system, not a direct measurement of every downstream biological effect.
Why directly measured free 25(OH)D still has limitations
Direct measurement avoids some assumptions required by calculation, but it does not eliminate analytical uncertainty. Free 25(OH)D exists at very low concentrations, making measurement technically demanding. Direct immunoassays were widely used in the human studies discussed here, and the studies themselves show that method choice and calculation assumptions materially affect comparison across datasets.
Analytical method matters at both ends of the comparison. In these studies, total 25(OH)D was commonly measured by LC-MS/MS, while DBP measurement was strongly method-dependent and direct free immunoassay results could not simply be replaced by calculated values. A result labelled “free vitamin D” therefore needs its method understood before it is compared across studies or converted into a clinical threshold.
For readers trying to understand the difference between the metabolite being measured and the assay used to measure it, Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D provides the metabolite-level testing context.
What can and cannot be concluded clinically
The evidence supports continued use of total 25(OH)D as a broadly useful conventional marker. It also supports recognising that total concentration is carrier-dependent and that free measurement can add interpretive information when DBP or albumin is markedly altered. It supports scepticism toward calculated free values when DBP assay performance or binding assumptions are uncertain.
The evidence does not establish a universal free 25(OH)D target, does not show that direct free measurement should replace total 25(OH)D in routine screening, and does not show that free concentration directly measures tissue vitamin D action. It also does not justify interpreting a rare DBP-null patient as evidence that ordinary low total 25(OH)D is clinically irrelevant.
The most defensible interpretation is therefore conditional. Ask what was measured, how it was measured, whether binding proteins are likely to be unusual, and what clinical question the number is being asked to answer.
Primary studies
Sollid ST et al. European Journal of Endocrinology, 2016. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D.
Nielson CM et al. Journal of Clinical Endocrinology & Metabolism, 2016. Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations.
Schwartz JB et al. Journal of Clinical Endocrinology & Metabolism, 2014. A Comparison of Measured and Calculated Free 25(OH) Vitamin D Levels in Clinical Populations.
Schwartz JB et al. Journal of Clinical Endocrinology & Metabolism, 2018. Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations.
Henderson CM et al. New England Journal of Medicine, 2019. Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.
Banerjee RR et al. Journal of the Endocrine Society, 2021. Very Low Vitamin D in a Patient With a Novel Pathogenic Variant in the GC Gene That Encodes Vitamin D-Binding Protein.
Bikle DD et al. Journal of Clinical Investigation, 1986. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels.
Related reading
Maternal Vitamin D Deficiency During Pregnancy Alters Hepatic Metabolism in Adult Female Offspring Without Overt Metabolic Dysfunction
This study aimed to comprehensively assess hepatic metabolic profiles in female offspring exposed to maternal VDD during gestation.
Original paper ↗Read more →The effects of vitamin D3 on lipogenesis in the liver and adipose tissue of pregnant rats
In the present study, we examined the effects of 1,25-dihydroxyvitamin D3 (VD3), an active hormonal form of nutritional vitamin D3, on lipid metabolism in pregnant rats.
Original paper ↗Read more →Maternal Vitamin D Adaptations During Pregnancy: Full Evidence Review
How pregnancy affects active, total and free vitamin D.
Read more →Free, Albumin-Bound and Total Vitamin D in the Blood: Full Study
Explore human evidence on free, albumin-bound and total vitamin D, including DBP binding, circulating fractions and what each measurement represents.
Read more →Free, Albumin-Bound and Total Vitamin D in the Blood: Study Summary
A concise study summary explaining free, albumin-bound and total vitamin D in blood and how vitamin D-binding protein shapes circulating levels.
Read more →Three-year follow-up of serum 25-hydroxyvitamin D, parathyroid hormone, and bone mineral density in nursing home residents who had received 12 months of daily bread fortification with 125 μg of vitamin D3
We conducted a single-arm clinical trial in institutionalized seniors, on the effects of high-dose vitamin D3-fortified bread daily intake (clinicaltrials.gov registration NCT00789503).
Original paper ↗Read more →Pregnancy-associated alterations in circulating vitamin D metabolites: higher total 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D without increased free 25-hydroxyvitamin D
Total 25-hydroxyvitamin D [25(OH)D], free 25-hydroxyvitamin D, and total 1,25-dihydroxyvitamin D [1,25(OH)2D] concentrations were compared between pregnant and nonpregnant women and across gestation using age-adjusted regression models.
Original paper ↗Read more →Disrupted Vitamin D Metabolism in Hepatocellular Carcinoma: Free and Bioavailable 25(OH)D as Novel Biomarkers of Hepatic Reserve and Clinical Risk
Correlations with Child: Pugh score, Barcelona Clinic Liver Cancer (BCLC) stage, and disease aetiology were evaluated.
Original paper ↗Read more →Relationship Between Total 25-Hydroxyvitamin D and Parathyroid Hormone Concentrations During Early Gestation in Indian Women
The inverse relationship between 25(OH)D and parathyroid hormone (PTH) concentrations was examined to define the breakpoint at which PTH was maximally suppressed using a segmented regression analysis.
Original paper ↗Read more →Serum free 25(OH)D concentrations and cardiovascular disease, heart failure, kidney function decline, and fracture: the health, aging, and body composition study
We evaluated the relationship of free vitamin D with incident cardiovascular disease (CVD), heart failure (HF), kidney function decline (KFD) and fracture, among 786 participants in the Health Aging and body composition study.
Original paper ↗Read more →Total 25(OH)D Concentration Moderates the Association between Caffeine Consumption and the Alkaline Phosphatase Level in Pregnant Women
This study aimed to examine the effect of 25-hydroxyvitamin D (25(OH)D) concentration on the association between caffeine consumption and mineral metabolism in pregnant women.
Original paper ↗Read more →Vitamin D-Binding Protein, Bioavailable, and Free 25(OH)D, and Mortality: A Systematic Review and Meta-Analysis
Introduction: Observational studies reported inverse associations between serum total 25-hydroxyvitamin D (25(OH)D) concentrations and mortality.
Original paper ↗Read more →25-Hydroxyvitamin D in pregnancy and genome wide cord blood DNA methylation in two pregnancy cohorts (MoBa and ALSPAC)
The aim of the study was to investigate whether maternal mid-pregnancy 25-hydroxyvitamin D concentrations are associated with cord blood DNA methylation.
Original paper ↗Read more →Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease
We evaluated the associations of longitudinal 25(OH)D trajectories with subsequent liver stiffness measurement (LSM) increases in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.
Original paper ↗Read more →Diverse Effects of Combinations of Maternal-Neonatal VDR Polymorphisms and 25-Hydroxyvitamin D Concentrations on Neonatal Birth Anthropometry: Functional Phenocopy Variability Dependence, Highlights the Need for Targeted Maternal 25-Hydroxyvitamin D Cut-Offs during Pregnancy
The aim of this study was to evaluate the combined effect of maternal and neonatal VDR polymorphisms (ApaI, TaqI, BsmI, FokI, Tru9I) and different maternal and neonatal 25(OH)D cut-offs on neonatal birth anthropometry.
Original paper ↗Read more →Liver Graft Pathology and Low Serum 25-Hydroxyvitamin D after Living Donor Liver Transplantation
Aims: We conducted this study to explore the interplay between VDR and CYP2R1 in liver graft and compared our findings with the pathological interpretation of serum 25(OH)D concentration.
Original paper ↗Read more →Long-term adherence and effects on grip strength and upper leg performance of prescribed supplemental vitamin D in pregnant and recently pregnant women of Somali and Swedish birth with 25-hydroxyvitamin D deficiency: a before-and-after treatment study
Muscular weakness and severe vitamin D deficiency is prevalent in Somali (veiled) pregnant women, Sweden.
Original paper ↗Read more →Plasma 25-Hydroxyvitamin D Concentrations are Associated with Polyunsaturated Fatty Acid Metabolites in Young Children: Results from the Vitamin D Antenatal Asthma Reduction Trial
The objective of the current analysis was to identify metabolites and metabolic pathways associated with plasma 25-hydroxyvitamin D [25(OH)D] concentrations.
Original paper ↗Read more →Review: Influence of 25(OH)D Blood Concentration and Supplementation during Pregnancy on Preeclampsia Development and Neonatal Outcomes
Briefly, 25-hydroxyvitamin D (25(OH)D) plays an essential role in embryogenesis and the course of intra: and postnatal periods and is crucially involved in the functioning of the mother: placenta: fetus system.
Original paper ↗Read more →Seasonal Variation in 25(OH)D at Aberdeen (57°N) and Bone Health Indicators: Could Holidays in the Sun and Cod Liver Oil Supplements Alleviate Deficiency?
The aim of this longitudinal study, was to assess predictors of seasonal variation of 25-hydroxy-vitamin D (25(OH)D) (including use of supplements and holidays in sunny destinations) at a northerly latitude in the UK (57°N) in relation to bone health indicators.
Original paper ↗Read more →Sunlight exposed body surface area is associated with serum 25-hydroxyvitamin D (25(OH)D) level in pregnant Minangkabau women, Indonesia
This study was aimed to elucidate the association of sunlight exposed body surface area with serum 25(OH)D in pregnant Minangkabau women of Indonesia.
Original paper ↗Read more →Original sources
Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D
Sollid ST et al. European Journal of Endocrinology, 2016.
Publication details
Sollid ST et al. European Journal of Endocrinology, 2016. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D.
Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations
Nielson CM et al. Journal of Clinical Endocrinology & Metabolism, 2016.
Publication details
Nielson CM et al. Journal of Clinical Endocrinology & Metabolism, 2016. Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations.
A Comparison of Measured and Calculated Free 25(OH) Vitamin D Levels in Clinical Populations
Schwartz JB et al. Journal of Clinical Endocrinology & Metabolism, 2014.
Publication details
Schwartz JB et al. Journal of Clinical Endocrinology & Metabolism, 2014. A Comparison of Measured and Calculated Free 25(OH) Vitamin D Levels in Clinical Populations.
Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations
Schwartz JB et al. Journal of Clinical Endocrinology & Metabolism, 2018.
Publication details
Schwartz JB et al. Journal of Clinical Endocrinology & Metabolism, 2018. Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations.
Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene
Henderson CM et al. New England Journal of Medicine, 2019.
Publication details
Henderson CM et al. New England Journal of Medicine, 2019. Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.
Very Low Vitamin D in a Patient With a Novel Pathogenic Variant in the GC Gene That Encodes Vitamin D-Binding Protein
Banerjee RR et al. Journal of the Endocrine Society, 2021.
Publication details
Banerjee RR et al. Journal of the Endocrine Society, 2021. Very Low Vitamin D in a Patient With a Novel Pathogenic Variant in the GC Gene That Encodes Vitamin D-Binding Protein.
Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels
Bikle DD et al. Journal of Clinical Investigation, 1986.
Publication details
Bikle DD et al. Journal of Clinical Investigation, 1986. Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels.